When T-helper cells don't help: Immunopathology during concomitant infection

Quarterly Review of Biology

Volumn 77, Issue 4, 2002, Pages 409-434

  Graham, Andrea L ^a,b  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Darwinian medicine; Ecological immunology; Inducible defense; Phenotypic plasticity; Schistosomiasis; Th subsets; Virulence

Indexed keywords

ANIMAL; ANIMAL PARASITOSIS; BIOLOGICAL MODEL; DISEASE MODEL; HELPER CELL; HOST PARASITE INTERACTION; HUMAN; IMMUNOLOGY; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; REVIEW; SCHISTOSOMA MANSONI; TOXOPLASMA;

ANIMALS; DISEASE MODELS, ANIMAL; HOST-PARASITE RELATIONS; HUMANS; MODELS, IMMUNOLOGICAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; T-LYMPHOCYTES, HELPER-INDUCER; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL;

ANIMALIA; DARWINIA; SCHISTOSOMA; SCHISTOSOMA MANSONI; TOXOPLASMA; TOXOPLASMA GONDII;

EID: 0036951285     PISSN: 00335770     EISSN: None     Source Type: Journal    
DOI: 10.1086/344414     Document Type: Review

References (156)

1. Actor J K, Shirai M, Kullberg M C, Buller R M, Sher A, Berzofsky J A. 1993. Helminth infection results in decreased virus-specific CD8 + cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proceedings of the National Academy of Science of the United States of America 90:948-952.
2. Adler F R, Harvell C D. 1990. Inducible defenses, phenotypic variability and biotic environments. Trends in Ecology & Evolution 5:407-410.
3. Agur Z. 1989. Optimizing the immune control of parasitic invasion. Pages 107-115 in Theories of Immune Networks, edited by H Atlan and I R Cohen. Berlin: Springer-Verlag.
4. Allen J E, Maizels R M. 1996. Immunology of human helminth infection. International Archive of Allergy and Immunology 109:3-10.
5. Allen J E, Maizels R M. 1997. Th1-Th2: reliable paradigm or dangerous dogma? Immunology Today 18: 387-392.
6. Anderson R M, May R M. 1991. Infectious Diseases of Humans: Dynamics and Control. Oxford: Oxford University Press.
7. Araujo M I, Bliss S K, Suzuki Y, Alcaraz A, Denkers E Y, Pearce E J. 2001. Interleukin-12 promotes pathologic liver changes and death in mice co-infected with Schistosoma mansoni and Toxoplasma gondii. Infection and Immunity 69:1454-1462.
8. Atlan H, Cohen I R, editors. 1989. Theories of Immune Networks. Berlin: Springer-Verlag.
9. Behnke J M, Barnard C J, Wakelin D. 1992. Understanding chronic nematode infections: evolutionary considerations, current hypotheses and the way forward. International Journal for Parasitology 22:861-907.
10. Bofill M, Janossy G, Lee C A, MacDonald-Burns D, Phillips A-N, Sabin C, Timms A, Johnson M A, Kernoff P B A. 1992. Laboratory control values for CD4 and CD8 T lymphocyte - implications for HIV-1 diagnosis. Clinical and Experimental Immunology 88:243-252.
11. Booth M, Mayombana C, Kilima P. 1998. The population biology and epidemiology of schistosome and geohelminth infections among schoolchildren in Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene 92:491-495.
12. Boros D L. 1989. Immunopathology of Schistosoma mansoni infection. Clinical Microbiology Reviews 2: 250-269.
13. Brunet L R, Dunne D W, Pearce E J. 1998. Cytokine interaction and immune responses during Schistosoma mansoni infection. Parasitology Today 14:422-427.
14. Buck A A, Anderson R I, MacRae A A. 1978a. Epidemiology of poly-parasitism. IV. Combined effects on the state of health. Tropenmedizin und Parasitologie 29:253-268.
15. Buck A A, Anderson R I, MacRae A A, Fain A. 1978b. Epidemiology of poly-parasitism. I. Occurrence, frequency, and distribution of multiple infections in rural communities in Chad, Peru, Afghanistan, and Zaire. Tropenmedizin und Parasitologie 29:61-70.
16. Buck A A, Anderson R I, MacRae A A, Fain A. 1978c. Epidemiology of poly-parasitism. II. Types of combinations, relative frequency, and associations of multiple infections. Tropenmedizin und Parasitologie 29:137-144.
17. Bull J J. 1994. Perspective: virulence. Evolution 48:1423-1437.
18. Butcher E C, Picker L J. 1996. Lymphocyte homing and homeostasis. Science 272:60-66.
19. Butterworth A E, Curry A J, Dunne D W, Fultord A J C, Kimani G, Kariuki H C, Klumpp R, Koech D, Mbugua G, Ouma J H, Roberts M, Thiong'o F W, Capron A, Sturrock R F. 1994. Immunity and morbidity in human schistosomiasis mansoni. Tropical and Geographical Medicine 46:197-208.
20. Butterworth A E, Dunne D W, Fulford A J C, Thorne K J I, Gachuhi K, Ouma J H, Sturrock R F. 1992. Human immunity to Schistosoma mansoni: observations on mechanisms, and implications for control. Immunological Investigations 21:391-407.
21. Chan M S, Anderson R M, Medley G F, Bundy D A P. 1996a. Dynamic aspects of morbidity and acquired immunity in schistosomiasis control. Acta Tropica 62:105-117.
22. Chan M S, Guyatt H L, Bundy D A P, Medley G F. 1996b. Dynamic models of schistosomiasis morbidity. American Journal of Tropical Medicine and Hygiene 55:52-62.
23. Chieffi P P. 1992. Interrelationship between schistosomiasis and concomitant diseases. Memorias de Instituto Oswaldo Cruz 87:291-296.
24. Clark I A, Chaudhri G. 1989. Relationship between inflammation and immunopathology of malaria. Pages 127-146 in Malaria: Host Responses to Infection, edited by M M Stevenson. Boca Raton (FL): CRC Press.
25. Clerici M, Shearer G M. 1994. The Th1-Th2 hypothesis of HIV infection: new insights. Immunology Today 15:575-581.
26. Combes C. 1997. Fitness of parasites: pathology and selection. International Journal for Parasitology 27:1-10.
27. Corbett E L, Butterworth A E, Fulford A J C, Ouma J H, Sturrock R F. 1992. Nutritional status of children with schistosomiasis mansoni in two different areas of Machakos district, Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene 86: 266-273.
28. Curry A J, Else K J, Jones F, Bancroft A, Grencis R K, Dunne D W. 1995. Evidence that cytokine-mediated immune interactions induced by Schistosoma mansoni alter disease outcome in mice concurrently infected with Trichuris muris. Journal of Experimental Medicine 181:769-774.
29. Del Prete G, Romagnani S. 1996. Human Th1 and Th2 cells: functional properties, regulation of development and role in disease. Pages 18-26 in T-cell Subsets and Cytokines Interplay in Infectious Diseases, edited by A S Mustafa et al. Basel: Karger.
30. Denkers E Y, Gazzinelli R T. 1998. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clinical Microbiology Reviews 11:569-588.
31. Despommier D D, Karapelou J W. 1987. Parasite Life Cycles. New York: Springer-Verlag.
32. Doenhoff M. J. 1997. A role for granulomatous inflammation in the transmission of infectious disease: schistosomiasis and tuberculosis. Parasitology 115:S113-S125.
33. Ebert D, Hamilton W D. 1996. Sex against virulence: the coevolution of parasitic diseases. Trends in Ecology & Evolution 11:79-82.
34. Else K J, Grencis R K. 1991. Cellular immune responses to the murine nematode parasite Trichuris muris. I. Differential cytokine production during acute or chronic infection. Immunology 72:508-513.
35. Fahey J L, Prince H, Weaver M, Groopman J, Visscher B, Schwartz K, Detels R. 1984. Quantitative changes in T-helper or T-suppressor/cytotoxic lymphocyte subsets that distinguish Acquired Immune Deficiency Syndrome from other immune subset disorders. The American Journal of Medicine 76:95-100.
36. Farmer J D, Kauffman S A, Packard N H, Perelson A S. 1987. Adaptive dynamic networks as models for the immune system and auto-catalytic sets. Annals of the New York Academy of Sciences 504:118-131.
37. Farmer J D, Packard N H, Perelson A S. 1986. The immune system, adaptation, and machine learning. Physica 22D:187-204.
38. Fearon D T, Locksley R M. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50-54.
39. Fishman M A, Perelson A S. 1999. Th1/Th2 differentiation and cross-regulation. Bulletin of Mathematical Biology 61:403-436.
40. Freitas A, Rocha B B. 1993. Lymphocyte lifespans: homeostasis, selection, and competition. Immunology Today 14:25-29.
41. Frost S D W. 1999. The immune system as an inducible defense. Pages 104-126 in The Ecology and Evolution of Inducible Defenses, edited by R Tollrian and C D Harvell. Princeton (NJ): Princeton University Press.
42. Fulford A J C, Mbugua G G, Ouma J H, Kariuki H C, Sturrock R F, Butterworth A E. 1991. Differences in the rate of hepatosplenomegaly due to Schistosoma mansoni infection between two areas in Machakos district, Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene 85:481-488.
43. Gemmill A W, Read A F. 1998. Counting the cost of disease resistance. Trends in Ecology & Evolution 13:8-9.
44. Graham A L. 2001. Use of an optimality model to solve the immunological puzzle of concomitant infection. Parasitology 122:S61-S64.
45. Graham M B, Braciale V L, Braciale T J. 1994. Influenza virus-specific CD4 + T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. Journal of Experimental Medicine 180:1273-1282.
46. Grencis R K. 1996. T cell and cytokine basis of host variability in response to intestinal nematode infections. Parasitology 112:S31-S37.
47. Gryseels B, Stelma F F, Talla I, van Dam G J, Polman K, Sow S, Diaw M, Sturrock R F, DoehringSchwerdtfeger E, Kardorff R, Decam C, Niang M, Deelder A M. 1994. Epidemiology, immunology, and chemotherapy of Schistosoma mansoni infections in a recently-exposed community in Senegal. Tropical and Geographical Medicine 46:209-219.
48. Hammouda N A, El-Nassery S F, Bakr M E, El-Gebali W M, Hassan A M. 1994. Effect of toxoplasmosis on experimental schistosomiasis. Journal of the Egyptian Society of Parasitology 24:395-406.
49. Harvell C D. 1990a. The ecology and evolution of inducible defenses. Quarterly Review of Biology 65: 323-340.
50. Harvell C D. 1990b. The evolution of inducible defence. Parasitology 100:S53-S61.
51. Harvell C D, Tollrian R. 1999. Why inducible defenses? Pages 3-9 in The Ecology and Evolution of Inducible Defenses, edited by R Tollrian and C D Harvell. Princeton (NJ): Princeton University Press.
52. Heeney J L. 1995. AIDS: a disease of impaired Th-cell renewal? Immunology Today 16:515-520.
53. Hill A V S. 1998. The immunogenetics of human infectious diseases. Annual Review of Immunology 16:593-617.
54. Hill A V S, Motulsky A G. 1999. Genetic variation and human disease: the role of natural selection. Pages 50-61 in Evolution in Health and Disease, edited by S C Stearns. Oxford: Oxford University Press.
55. Hoffmann K F, Caspar P, Cheever A W, Wynn T A. 1998. IFN-gamma, IL-12, and TNF-alpha are required to maintain reduced liver pathology in mice vaccinated with Schistosoma mansoni eggs and IL-12. Journal of Immunology 161:4201-4210.
56. Ilmonen P, Taarna T, Hasselquist D. 2000. Experimentally-activated immune defense in female pied flycatchers results in reduced breeding success. Proceedings of the Royal Society of Biological Sciences Series B 267:665-670.
57. Infante-Duarte C, Kamradt T. 1999. Th1/Th2 balance in infection. Springer Seminars in Immunopathology 21:317-338.
58. Jacobson D L, Gange S J, Rose N R, Graham N M H. 1997. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clinical Immunology and Immunopathology 84: 223-243.
59. Jacobs P, Radzioch D, Stevenson M M. 1996. A Th1-associated increase in TNF-alpha expression in the spleen correlates with resistance to blood-stage malaria in mice. Infection and Immunity 64:535-541.
60. Janeway C A, Travers P, Walport M, Capra J D. 1999. Immunobiology: The Immune System in Health and Disease. New York: Elsevier Science.
61. Jokela J, Schmid-Hempel P, Rigby M C. 2000. Dr. Pangloss restrained by the red queen - steps towards a unified defence theory. Oikos 89:267-274.
62. Kaitala V, Heino M, Getz W M. 1997. Host-parasite dynamics and the evolution of host immunity and parasite fecundity strategies. Bulletin of Mathematical Biology 59:427-450.
63. Karanja D M S, Boyer A E, Strand M, Colley D G, Nahlen B L, Ouma J H, Secor W E. 1998. Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1. American Journal of Tropical Medicine and Hygiene 59:307-311.
64. Karanja D M S, Colley D G, Nahlen B L, Ouma J H, Secor W E. 1997. Studies on schistosomiasis in western Kenya: I. Evidence for immune-facilited excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections. American Journal of Tropical Medicine and Hygiene 56:515-521.
65. Karban R, Baldwin I T. 1997. Induced Responses to Herbiv̀ory. Chicago: University of Chicago Press.
66. Kloetzel K, Chieffi P P, Faleiros J J, Filho T J. 1977. Mortality and other parameters of concomitant infections in albino mice: the Schistosoma-Toxoplasma model. Tropical and Geographical Medicine 29:407-410.
67. La Flamme A C, Scott P, Pearce E J. 2002. Schistosomiasis delays lesion resolution during L. major infection by impairing parasite killing by macrophages. Parasite Immunology 24:339-345.
68. Laurence J. 1993. T-cell subsets in health, infectious disease, and idiopathic CD4 + T lymphocytopenia. Annals of Internal Medicine 119:55-62.
69. Levin B R, Lipsitch M, Bonhoeffer S. 1999. Population biology, evolution, and infectious disease: convergence and synthesis. Science 283:806-809.
70. Lipsitch M, Moxon R E. 1997. Virulence and transmissibility of pathogens: what is the relationship? Trends in Microbiology 5:31-37.
71. Lloyd S. 1995. Environmental influences on host immunity. Pages 327-335 in Ecology of Infectious Diseases in Natural Populations, edited B T Grenfell and A P Dobson. Cambridge: Cambridge University Press.
72. Lochmiller R L, Deerenberg C. 2000. Trade-offs in evolutionary immunology: just what is the cost of immunity? Oikos 88:87-98.
73. Lumsden R D. 1979. Morphological aspects of host-parasite interaction: some observations on the mammalian inflammatory response to helminth parasitism. Pages 49-70 in Host-Parasite Interfaces, edited by B B Nickol. New York: Academic Press.
74. Mahmoud A A, Strickland G T, Warren K S. 1977. Toxoplasmosis and the host-parasite relationship in murine schistosomiasis mansoni. Journal of Infectious Diseases 135:408-413.
75. Maizels R M, Bundy D A P, Selkirk M E, Smith D F, Anderson R M. 1993. Immunological modulation and evasion by helminth parasites in human populations. Nature 365:797-805.
76. Marshall A J, Brunet L R, van Gessel Y, Alcaraz A, Bliss S K, Pearce E J, Denkers E Y. 1999. Toxoplasma gondii and Schistosoma mansoni synergize to promote hepatocyte dysfunction associated with high levels of plasma TNF-alpha and early death in C57BL/6 mice. Journal of Immunology 163:2089-2097.
77. Matzinger P. 1994. Tolerance, danger, and the extended family. Annual Review of Immunology 12: 991-1045.
78. May R M, Anderson R M. 1990. Parasite-host coevolution. Parasitology 100:89-101.
79. McGuire W, D'Alessandro U, Stephens S, Olaleye B O, Langerock P, Greenwood B M, Kwiatkowski D. 1998. Levels of tumor necrosis factor and soluble TNF receptors during malaria fever episodes in the community. Transactions of the Royal Society of Tropical Medicine and Hygiene 92:50-53.
80. McGuire W, Knight J C, Hill A V S, Allsopp C E M, Greenwood B M, Kwiatkowski D. 1999. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. Journal of Infectious Diseases 179:287-290.
81. Mielke M E A, Ehlers S, Hahn H. 1993. The role of cytokines in experimental listeriosis. Immunobiology 189:285-315.
82. Mitchell G F. 1991. Coevolution of parasites and adaptive immune responses. Pages A2-A5 in Immunoparasitology Today, edited by C Ash and R B Gallagher. Cambridge: Elsevier Trend Journals.
83. Mitchison N A. 1990. The evolution of acquired immunity to parasites. Parasitology 100:S27-S34.
84. Moran N A. 1992. The evolutionary maintenance of alternative phenotypes. American Naturalist 139:971-989.
85. Morel B F, Kalagnanam J, Morel P A. 1992. Mathematical modeling of Th1-Th2 dynamics. Pages 171-190 in Theoretical and Experimental Insights into Immunology, edited by A S Perelson and G Weisbuch. Berlin: Springer-Verlag.
86. Moser M, Murphy K M. 2000. Dendritic cell regulation of Th1-Th2 development. Nature Immunology 1:199-205.
87. Mosmann T R, Cherwinski H M, Bond M W, Giedlin M A, Coffman R L. 1986. Two types of murine T cell clone: 1. Definition according to profiles of lymphokine activities and secreted proteins. Journal of Immunology 136:2348-2357.
88. Mosmann T R, Sad S. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunology Today 17:138-146.
89. Mounfford A P, Pearlman E. 1998. Interleukin-12 and the host response to parasitic helminths: the paradoxical effect on protective immunity and immunopathology. Parasite Immunology 20:509-517.
90. Murray C J L, Lopez A D. 1996a. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge (MA): Harvard School of Public Health.
91. Murray C J L, Lopez A D. 1996b. Global Health Statistics: A Compendium of Incidence, Prevalence, and Mortality Estimates for Over 200 Conditions. Cambridge (MA): Harvard School of Public Health.
92. Mwatha J K, Kimani G, Kamau T, Mbugua G G, Ouma J H, Mumo J, Fulford A J C, Jones F M, Butterworth A E, Roberts M B, Dunne D W. 1998. High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni. Journal of Immunology 160:1992-1999.
93. Nesse R M, Williams G C. 1994. Why We Get Sick: The New Science of Darwinian Medicine. New York: Times Books.
94. Nitz N M. 1997. Comorbidity. Pages 153-174 in Understanding Health Care Outcomes Research, edited by R L Kane. Gaithersburg (MD): Aspen Publishers.
95. Norris K, Evans M R. 2000. Ecological immunology: life history trade-offs and immune defense in birds. Behavioral Ecology 11:19-26.
96. Nunn C L, Gittleman J L, Antonovics J. 2000. Promiscuity and the primate immune system. Science 290:1168-1170.
97. Omer A H, McLaren M L, Johnson B K, Chanas A C, Brumpt I, Gardner P, Draper C C. 1981. A seroepidemiological survey in the Gezira, Sudan, with special reference to arboviruses. Journal of Tropical Medicine and Hygiene 84:63-66.
98. Orihel T C, Ash L R. 1995. Parasites in Human Tissues. Chicago (IL): American Society of Clinical Pathologists (ASCP) Press.
99. Owens I P F, Wilson K. 1999. Immunocompetence: a neglected life history trait or conspicuous red herring? Trends in Ecology & Evolution 14:170-172.
100. Padilla D K, Adolph S C. 1996. Plastic inducible morphologies are not always adaptive: the importance of time delays in a stochastic environment. Evolutionary Ecology 10:105-117.
101. Parham P, Ohta T. 1996. Population biology of antigen presentation by MHC Class I molecules. Science 272:67-74.
102. Parker G A, Maynard-Smith J. 1990. Optimality theory in evolutionary biology. Nature 348:27-33.
103. Pearce E J, Sher A. 1987. Mechanisms of immune evasion in schistosomiasis. Contributions to Microbiology and Immunology 8:219-232.
104. Penn D J, Potts W K. 1999. The evolution of mating preferences and major histocompatibility complex genes. American Naturalist 153:145-164.
105. Perelson A S, Mirmirani M, Oster G F. 1976. Optimal strategies in immunology. I. B-cell differentiation and proliferation. Journal of Mathematical Biology 3:325-367.
106. Perelson A S, Mirmirani M, Oster G F. 1978. Optimal strategies in immunology. II. B memory cell production. Journal of Mathematical Biology 5:213-256.
107. Perelson A S, Weisbuch G, editors. 1992. Theoretical and Experimental Insights into Immunology. Berlin: Springer-Verlag.
108. Petney T N, Andrews R H. 1998. Multiparasite communities in animals and humans: frequency, structure and pathogenic significance. International Journal for Parasitology 28:377-393.
109. Pritchard D I, Hewitt C, Moqbel R. 1997. The relationship between immunological responsiveness controlled by T-helper 2 lymphocytes and infections with parasitic helminths. Parasitology 115:S33-S44.
110. Quintiliani R. 1994. The epidemiology of mild, moderate, and severe asthma. Advances in Therapy 11: 70-77.
111. Raberg L, Nilsson J A, Ilmonen P, Stjernman M, Hasselquist D. 2000. The cost of an immune response: vaccination reduces parental effort. Ecology Letters 3:382-386.
112. Read A F. 1994. The evolution of virulence. Trends in Microbiology 2:73-76.
113. Read A F, Albon S D, Antonovics J, Apanius V, Dwyer G, Holt R D, Judson O, Lively C M, Martin-Lof A, McLean A R, Metz J A J, Schmid-Hempel P, Thrall P H, Via S, Wilson K. 1995. Group report: genetics and evolution of infectious diseases in natural populations. Pages 450-477 in Ecology of Infectious Diseases in Natural Populations, edited by B T Grenfell and A P Dobson. Cambridge: Cambridge University Press.
114. Read A F, Allen J E. 2000. The economics of immunity. Science 290:1104-1105.
115. Reeve H K. 1989. The evolution of conspecific acceptance thresholds. American Naturalist 133:407-435.
116. Reeve H K, Sherman P W. 1993. Adaptation and the goals of evolutionary research. Quarterly Review of Biology 68:1-32.
117. Ridge J P, Fuchs E J, Matzinger P. 1996. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271:1723-1726.
118. Roberts C W, Ferguson D J P, Jebbari H, Satoskar A, Bluethmann H, Alexander J. 1996. Different roles for interleukin-4 during the course of Toxoplasma gondii infection. Infection and Immunity 64:897-904.
119. Rollo C D. 1995. Phenotypes: Their Epigenetics, Ecology, and Evolution. London: Chapman and Hall.
120. Romagnani S. 1996. Th1 and Th2 in human diseases. Clinical Immunology and Immunopathology 80:225-235.
121. Rosa Brunet L, Beall M, Dunne D W, Pearce E J. 1999. Nitric oxide and the Th2 response combine to prevent severe hepatic damage during Schistosoma mansoni infection. Journal of Immunology 163:4976-4984.
122. Rosa Brunet L, Finkelman F D, Cheever A W, Kopf M A, Pearce E J. 1997. IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis. Journal of Immunology 159:777-785.
123. Sabin E A, Araujo M I, Carvalho E M, Pearce E J. 1996. Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. Journal of Infectious Disease 173:269-272.
124. Schlichting C D, Pigliucci M. 1998. Phenotypic Evolution: A Reaction Norm Perspective. Sunderland (MA): Sinauer Associates.
125. Sell S. 1987. Immunology, Immunopathology and Immunity. New York: Elsevier.
126. Shear H L, Ng C, Zhao Y. 1990. Cytokine production in lethal and non-lethal murine malaria. Immunology Letters 25:123-128.
127. Sheldon B C, Verhulst S. 1996. Ecological immunology: costly parasite defences and trade-offs in evolutionary ecology. Trends in Ecology & Evolution 11:317-321.
128. Sher A, Coffman R L. 1992. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annual Review of Immunology 10:385-409.
129. Sherman P W, Reeve H K, Pfennig D W. 1997. Recognition systems. Pages 69-96 in Behavioural Ecology: An Evolutionary Approach, edited by J R Krebs and N B Davies. London: Blackwell Science.
130. Sih A, Englund G, Wooster D. 1998. Emergent impacts of multiple predators on prey. Trends in Ecology & Evolution 13:350-355.
131. Stearns S C. 1989a. The evolutionary significance of phenotypic plasticity. BioScience 39:436-445.
132. Stearns S C. 1989b. Tradeoffs in life history evolution. Functional Ecology 3:259-268.
133. Stearns S C, editor. 1999. Evolution in Health and Disease. Oxford: Oxford University, Press.
134. Stevenson M M, Tam M F. 1993. Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi AS infection in resistant and susceptible mice. Clinical and Experimental Immunology 91:77-83.
135. Taylor B E, Gabriel W. 1992. To grow or not to grow: optimal resource allocation for Daphnia. American Naturalist 139:248-266.
136. Taylor B E, Gabriel W. 1993. Optimal adult growth of Daphnia in a seasonal environment. Functional Ecology 7:513-521.
137. Thompson J N. 1994. The Coevolutionary Process. Chicago (IL): University, of Chicago Press.
138. Tollrian R, Dodson S I. 1999. Inducible defenses in Cladocera: constraints, costs, and multipredator environments. Pages 177-202 in The Ecology and Evolution of Inducible Defenses, edited by R Tollrian and S I Dodson. Princeton (NJ): Princeton University Press.
139. Toossi Z, Ellner JJ. 1998. Host response to Mycobacterium tuberculosis. Frontiers in Bioscience 3:E133-E140.
140. Trevathan W R, Smith E O, McKenna J J, editors. 1999. Evolutionary Medicine. Oxford: Oxford University Press.
141. Tsegaye A, Messele T, Tilahun T, Hailu E, Sahlu T, Doorly R, Fontanet A L, Rinke de Wit T F. 1999. Immunohematological reference ranges for adult Ethiopians. Clinical and Diagnostic Laboratory Immunology 6:410-414.
142. Tshikuka J-G, Scott M E, Gray-Donald K, Kalumba O-N. 1996. Multiple infection with Plasmodium and helminths in communities of low and relatively high socio-economic status. Annals of Tropical Medicine and Parasitology 90:277-293.
143. Vennervald B J, Ouma J H, Butterworth A E. 1998. Morbidity in schistosomiasis: assessment, mechanisms, and control. Parasitology Today 14:385-390.
144. Via S, Gomulkiewicz R, De Jong G, Scheiner S M, Schlichting C D, Van Tienderen P H. 1995. Adaptive phenotypic plasticity: consensus and controversy. Trends in Ecology & Evolution 10:212-217.
145. Vogel T U, Evans D T, Urvater J A, O'Connor D H, Hughes A L, Watkins D I. 1999. Major histocompatibility complex class I genes in primates: coevolution with pathogens. Immunological Reviews 167:327-337.
146. Webster H K, Pattanapanyasat K, Phanupak P, Wasi C, Chuenchitra C, Ybarra L, Buchner L. 1996. Lymphocyte immunophenotype reference ranges in healthy Thai adults: implications for management of HIV/AIDS in Thailand. Southeast Asian Journal of Tropical Medicine and Hygiene 27:418-429.
147. Webster M, Correa O R, Gazzinelli G, Viana I R C, Fraga L A D O, Silveira A M S, Dunne D W. 1997. Factors affecting high and low human IgE responses to schistosome worm antigens in an area of Brazil endemic for Schistosoma mansoni and hookworm. American Journal of Tropical Medicine and Hygiene 57:487-494.
148. Weinstock J V. 1992. The pathogenesis of granulomatous inflammation and organ injury in schistosomiasis: interactions between the schistosome ova and the host. Immunological Investigations 21:455-475.
149. World Health Organization (WHO). 1985. The Control of Schistosomiasis: Second Report of the WHO Expert Committee. Geneva: World Health Organization.
150. World Health Organization (WHO). 1998a. Disease Status Report. Geneva: World Health Organization.
151. World Health Organization (WHO). 1998b. World Health Report. Geneva: World Health Organization.
152. World Health Organization (WHO). 1998c. World Health Statistics Annual, 1996. Geneva: World Health Organization.
153. World Health Organization (WHO). 1999. Workplan of the Pathogenesis Committee. Geneva: World Health Organization.
154. Williams G C, Nesse R. 1991. The dawn of Darwinian medicine. Quarterly Review of Biology, 66:1-22.
155. Wimalasundera S S, Katz D R, Chain B M. 1997. Characterization of the T-cell response to human rhinovirus in children: implications for understanding the immunopathology of the common cold. Journal of Infectious Diseases 176:755-759.
156. Wynn T A, Cheever A W, Jankovic D, Poindexter R W, Caspar P, Lewis F A, Sher A. 1995. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376:594-596.